Search
Statistics
We have 222 registered usersThe newest registered user is raheelmemon
Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Early Coadministration of Clonazepam with Sertraline for Panic disorder
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Early Coadministration of Clonazepam with Sertraline for Panic disorder
Early Coadministration of Clonazepam with Sertraline for Panic disorder
Arch Gen Psychiatry. 2001 Jul;58(7):681-6.
Although this medication combination is widely used in clinical practice, there is no well-tested, optimal method of coadministering these medications for the treatment of panic disorder.
The purpose of this study was to test the efficacy of early coadministration of clonazepam with sertraline in the treatment of panic disorder.
- Patients (N=50) were treated with flexible-dose, openlabel sertraline (target dose, 100 mg/d) for 12 weeks.
- In addition, for the first 4 weeks of the trial, patients were randomly assigned to receive either placebo clonazepam (n=26)
or active clonazepam (0.5 mg by mouth 3 times daily) (n=24),
- followed by 3 weeks of tapered doses
- After the tapering period, open-label sertraline treatment was continued through the end of the study.
- Patients did not receive cognitive behavioral therapy or any other psychotherapy at this time
An intent-to-treat analysis revealed a much greater proportion of responders in the sertraline/clonazepam compared with the sertraline/placebo group at the end of week 1 of the trial (41% vs 4%) (P=.003).
There was a significant between-group difference at the end of week 3 with 14 (63%) of 22 of the sertraline/clonazepam group responding to treatment vs 8 (32%) of 25 of the sertraline/placebo group (P =.05).
These data indicate that rapid stabilization of panic symptoms can be safely achieved with a sertraline/ clonazepam combination, supporting the clinical utility of this type of regimen for facilitating early improvement of panic symptoms relative to sertraline alone.
Read the full article here: Archives of Gen Psychiatry
Arch Gen Psychiatry. 2001 Jul;58(7):681-6.
Although this medication combination is widely used in clinical practice, there is no well-tested, optimal method of coadministering these medications for the treatment of panic disorder.
The purpose of this study was to test the efficacy of early coadministration of clonazepam with sertraline in the treatment of panic disorder.
- Patients (N=50) were treated with flexible-dose, openlabel sertraline (target dose, 100 mg/d) for 12 weeks.
- In addition, for the first 4 weeks of the trial, patients were randomly assigned to receive either placebo clonazepam (n=26)
or active clonazepam (0.5 mg by mouth 3 times daily) (n=24),
- followed by 3 weeks of tapered doses
- After the tapering period, open-label sertraline treatment was continued through the end of the study.
- Patients did not receive cognitive behavioral therapy or any other psychotherapy at this time
An intent-to-treat analysis revealed a much greater proportion of responders in the sertraline/clonazepam compared with the sertraline/placebo group at the end of week 1 of the trial (41% vs 4%) (P=.003).
There was a significant between-group difference at the end of week 3 with 14 (63%) of 22 of the sertraline/clonazepam group responding to treatment vs 8 (32%) of 25 of the sertraline/placebo group (P =.05).
These data indicate that rapid stabilization of panic symptoms can be safely achieved with a sertraline/ clonazepam combination, supporting the clinical utility of this type of regimen for facilitating early improvement of panic symptoms relative to sertraline alone.
Read the full article here: Archives of Gen Psychiatry
Similar topics
» Clonazepam in treatment of Panic Disorder with or without agoraphobia: Dose-Response Study of Efficacy, Safety, and Discontinuance
» panic disorder
» Sertraline or mirtazapine for depression in dementia
» Psychopharmacology Weekly Question Series- Sertraline
» Mood Switch in Bipolar Depression: Comparison of Adjunctive Venlafaxine, Bupropion and Sertraline
» panic disorder
» Sertraline or mirtazapine for depression in dementia
» Psychopharmacology Weekly Question Series- Sertraline
» Mood Switch in Bipolar Depression: Comparison of Adjunctive Venlafaxine, Bupropion and Sertraline
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Sat Sep 10, 2016 1:45 pm by Admin
» L-Methylfolate: Who Will benefit
Sat Sep 03, 2016 3:00 pm by Admin
» Vitamins & Supplements in Clinical Practice.
Sun Aug 21, 2016 12:27 pm by Admin
» Imaging Biomarkers for Outcomes in Mild TBI
Fri Jul 22, 2016 12:37 pm by Admin
» Q.5 Clozapine Neutopenia
Mon Jul 11, 2016 8:43 pm by Admin
» Treating Disorders!
Mon Jul 04, 2016 1:52 am by troymackys
» Cortical Abnormalities in Adults & Adolescents with MDD
Sun Jul 03, 2016 12:59 pm by Admin
» Efficacy of Antipsychotics in Pediatric Acute Mania
Wed Jun 22, 2016 8:46 pm by Admin
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?
Tue Jun 21, 2016 9:34 pm by Admin